\-\ Texto\\:\\ \ \(0\)\
\-\ non\\-contributory\ \(73\)\
\-\ surgery\ \(977\)\
\-\ \\â\\€\\¢\\ large\\ bifrontal\\,\\ calcified\\,\\ mass\\ arising\\ from\\ the\\ ethmoid\\ roof\ \(0\)\
\-\ \\â\\€\\¢\\ profuse\\ enhancement\ \(0\)\
\-\ \\â\\€\\¢\\ reactive\\ hyperostosis\\ \\(sclerotic\\ bony\\ changes\\)\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ \\"spoke\\-wheel\\"\\ flow\\ voids\\ within\\ center\\ of\\ mass\\.\ \(0\)\
\-\ \\â\\€\\¢\\ massive\\ amount\\ of\\ associated\\ intraaxial\\ vasogenic\\ edema\ \(0\)\
\-\ meningioma\\ ethmoid\\ roof\ \(0\)\
\-\ \\â\\€\\¢\\ meningioma\ \(7\)\
\-\ \\â\\€\\¢\\ olfactory\\ neuroblastoma\ \(0\)\
\-\ \\â\\€\\¢\\ metastatic\\ disease\ \(13\)\
\-\ \\â\\€\\¢\\ hemangiopericytoma\ \(1\)\
\-\ 55\\ year\\ old\\ woman\\ with\\ syncope\\.\ \(1\)\
\-\ history\\ of\\ lymphoma\\ treated\\ many\\ years\\ previously\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ roof\\:\\ 0\\.3276241517205919\ \(0\)\
\-\ ethmoid\\:\\ 0\\.3176877049851725\ \(0\)\
\-\ profuse\\:\\ 0\\.23210897042072529\ \(0\)\
\-\ meningioma\\:\\ 0\\.22762903233094167\ \(0\)\
\-\ bifrontal\\:\\ 0\\.19306482013912057\ \(0\)\
\-\ olfactory\\:\\ 0\\.19109154751073656\ \(0\)\
\-\ syncope\\:\\ 0\\.1790565417320211\ \(0\)\
\-\ intraaxial\\:\\ 0\\.17673969020334226\ \(0\)\
\-\ hyperostosis\\:\\ 0\\.1746083933999929\ \(0\)\
\-\ hemangiopericytoma\\:\\ 0\\.16121225678728002\ \(0\)\
\-\ massive\\:\\ 0\\.1561519666608652\ \(0\)\
\-\ voids\\:\\ 0\\.1556447704623533\ \(0\)\
\-\ vasogenic\\:\\ 0\\.14940338396285172\ \(0\)\
\-\ neuroblastoma\\:\\ 0\\.13955090684309526\ \(0\)\
\-\ center\\:\\ 0\\.13744073419422873\ \(0\)\
\-\ 55\\:\\ 0\\.13055247600372333\ \(0\)\
\-\ reactive\\:\\ 0\\.13035740556841113\ \(0\)\
\-\ sclerotic\\:\\ 0\\.12741626766345712\ \(0\)\
\-\ calcified\\:\\ 0\\.12235932452910618\ \(0\)\
\-\ previously\\:\\ 0\\.12193099901433091\ \(0\)\
\-\ amount\\:\\ 0\\.121509454663954\ \(0\)\
\-\ arising\\:\\ 0\\.1206858736919185\ \(0\)\
\-\ many\\:\\ 0\\.11975615846402637\ \(0\)\
\-\ bony\\:\\ 0\\.1170291545928665\ \(0\)\
\-\ mass\\:\\ 0\\.11603590374491446\ \(0\)\
\-\ flow\\:\\ 0\\.10116952610931104\ \(0\)\
\-\ treated\\:\\ 0\\.09458623841741783\ \(0\)\
\-\ years\\:\\ 0\\.09310658025028157\ \(0\)\
\-\ changes\\:\\ 0\\.09179602423395217\ \(0\)\
\-\ edema\\:\\ 0\\.09059057300387278\ \(0\)\
\-\ lymphoma\\:\\ 0\\.09045994153010999\ \(0\)\
\-\ of\\:\\ 0\\.08917264300859158\ \(0\)\
\-\ enhancement\\:\\ 0\\.08742528001262188\ \(0\)\
\-\ metastatic\\:\\ 0\\.0833041050329047\ \(0\)\
\-\ surgery\\:\\ 0\\.08166252575147266\ \(0\)\
\-\ associated\\:\\ 0\\.08005745690208972\ \(0\)\
\-\ woman\\:\\ 0\\.07910484490632573\ \(0\)\
\-\ large\\:\\ 0\\.07610446470319279\ \(0\)\
\-\ multiple\\:\\ 0\\.07429273881146797\ \(0\)\
\-\ within\\:\\ 0\\.0699558823414185\ \(0\)\
\-\ disease\\:\\ 0\\.06375805530944138\ \(0\)\
\-\ from\\:\\ 0\\.06032429620126446\ \(0\)\
\-\ history\\:\\ 0\\.05803079963884839\ \(0\)\
\-\ year\\:\\ 0\\.046809529011121113\ \(0\)\
\-\ old\\:\\ 0\\.04495335137125935\ \(0\)\
\-\ the\\:\\ 0\\.03030757258481614\ \(0\)\
\-\ with\\:\\ 0\\.029741974547180184\ \(0\)\
